Uncategorized Archives - Page 113 of 145

MondayJan 04, 2021 2:08 pm

CNS Pharmaceuticals (NASDAQ: CNSP) Conducts Public Offering Funding Effort, Appears in Syndicated Broadcast on Brain Cancer Drug Advances

Neuro-oncology drug developer CNS Pharmaceuticals is completing an underwritten public offering of common stock shares and warrants in a bid to fund its upcoming Phase 2 trials for a candidate in fighting glioblastoma brain cancers CNS’s Phase 2 trials are scheduled to begin during Q1 of 2021, building on a Phase 1 trial in which 44 percent of patients saw improvement and one patient has survived cancer-free for nearly 15 years The company has designed an ambitious, adaptive trial that allows for an interim analysis of data and adjustments for efficiency in bringing the drug candidate, Berubicin, to hoped-for approval…

MondayJan 04, 2021 12:43 pm

Brain Scientific Inc. (BRSF) Offers Solutions to Flatten COVID-19 Curve

Over one-third of hospitalized individuals are in danger of suffering neurological issues Traditional EEGs present various challenges, including cross-contamination NeuroCap(TM) makes EEGs more accessible, sanitary Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company with two FDA-cleared products, provides next-gen solutions to the neurology market. Neurological care that reduces the opportunity of cross-contamination is critically needed in the effort to combat COVID-19. According to the CDC's national forecast data, the United States is predicted to report a new record of COVID-19 cases, anticipated to number between 1 million and 2.3 million new cases the week ending Jan. 2, 2021 (https://ibn.fm/NveF2). A recent…

MondayJan 04, 2021 12:15 pm

Genetics May Help Prevent Decline in Cognitive Function

While some individuals suffer from dementia or Alzheimer’s as they get older, others tend to remain sharp well past the age of 80. German researchers have found the reason for this: an individual’s genes. The researchers’ conclusion is based on findings from a study that involved studying the brain images of 94 participants who were 80 years old and above. The images were made up of the amount of beta-amyloid protein plaques and tau protein tangles discovered in the participants’ brains. Researchers found that individuals who had lower scores on memory tests were those who were aging normally. These participants…

ThursdayDec 31, 2020 3:00 pm

Study Discovers HIV Increases Risks of Developing Cervical Cancer

A team of researchers from the Technical University of Munich have measured how an HIV infection affects cervical cancer development. HIV, the human immunodeficiency virus in full, is a virus that attacks an individual’s cells, making it harder for the body to fight infections, which makes one more vulnerable to other diseases and infections. The study was reported in “The Lancet Global Health” journal. Statistics from WHO show that cervical cancer is the fourth most common cancer type in women. Approximately 580,000 women were diagnosed with cervical carcinoma globally in 2018. It is estimated that nearly 311,000 of these women…

ThursdayDec 31, 2020 12:58 pm

United Medical Equipment Business Solutions Network Inc. Offers Medication Management App to Support Caregivers

An estimated 7,000 to 9,000 people die every year in the U.S. due to medication errors A sizeable percentage of individuals dealing with medication mismanagement are older United Medical’s medication app offers 11 functionalities designed for health-care professionals, caregivers, students and family members Each year, in the United States alone, an estimated 7,000 to 9,000 people die due to a medication error while hundreds of thousands of others experience adverse reactions or other complications related to medications, reports the National Center for Biotechnology Information (“NCBI”) (https://ibn.fm/cUBFl). United Medical Equipment Business Solutions Network is paying close attention to stats like these…

WednesdayDec 30, 2020 3:21 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Reports 100% Disease Control in Banana Study

MustGrow study conducted by third-party lab reports 100% control of ravaging disease Fusarium wilt TR4 has devastated $25-billion global banana industry Next step in testing will evaluate patented biopesticide technology in additional lab and field settings MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) has released potentially industry-changing results for its initial Colombia laboratory test evaluating the effect of its proprietary mustard-derived organic biopesticide formulation on the disease Fusarium wilt TR4. MustGrow’s study, which was conducted and reported via third-party laboratory CyberAgrot SAS in Colombia using Instituto Colombiano Agropecuario (“ICA”) official protocols, reports 100% control of the disease (https://ibn.fm/XhRSH). Sometimes called the…

WednesdayDec 30, 2020 1:00 pm

Prostate Cancer Regulator May Be Missing Link for Coronavirus Treatment

Scientists now have an encouraging lead on a coronavirus treatment after borrowing a page from prostate cancer. Two proteins — TMPRSS2 and ACE2 — assist the coronavirus in accessing an individual’s body and multiplying within the body’s cells. Arul Chinnaiyan, who is director of the Michigan Center for Translational Pathology, is familiar with the TMPRSS2 protein, seeing as it was his lab that discovered that the protein merges with the ETS gene to cause a majority of the prostate cancers. The researchers at the lab were also aware that the androgen receptor regulated the TMPRSS2 protein. Earlier this year, Chinnaiyan's laboratory…

WednesdayDec 30, 2020 12:40 pm

Brain Scientific Inc. (BRSF) Launches Latest Version of NeuroCap at Largest Global Conference for Neuro Specialists

BRSF presented a new version of NeuroCap(TM), a revolutionary disposable EEG headset Latest version presented to international medical audience includes velcro enhancements for better adhesion Brain Scientific appears well placed to capitalize on growing need for neurodiagnostic procedures Brain Scientific (OTCQB: BRSF) a neurology-focused medical device company, presented updates on its proprietary brain diagnostics technology at AES2020, the virtual annual meeting of the American Epilepsy Society, the world's largest scientific meeting focused on epilepsy and clinical neurophysiology. BRSF released the latest version of its disposable electroencephalogram (“EEG”) device in October 2020: the NeuroCap with velcro enhancements, which provide better adhesion,…

TuesdayDec 29, 2020 2:30 pm

Smartphone Cameras Can Now Be Used in Diagnosing Viral Diseases

A group of scientists from a Harvard Medical School teaching hospital, Brigham and Women’s Hospital, has designed a system that uses a smartphone camera to check for disease-causing infections. The study was reported in the “Science Advances” journal. In the paper, the team of researchers explains how the system works. The system requires a smartphone system that utilizes a deep learning algorithm that has been trained and an external catalytic microchip device. The coronavirus pandemic has affected most if not all countries across the globe, with most industries also experiencing the detrimental effects caused by the pandemic. To be better…

TuesdayDec 29, 2020 11:42 am

Hour of Truth Approaching in CNS Pharmaceuticals (NASDAQ: CNSP) Testing of Drug Candidate Against Deadly Brain Cancer

A novel anthracycline believed to be effective in combatting deadly glioblastoma brain cancers by crossing the blood-brain barrier and zeroing in on the tumor will begin Phase 2 trials during Q1 of next year The drug, Berubicin, is being developed by CNS Pharmaceuticals after initial testing nearly 15 years ago resulted in improvements among some subjects, including one who has survived cancer-free since that time The company, in collaboration with Polish sub-licensee partner WPD Pharmaceuticals, plans a multinational staged series of trials that will attempt to keep time and costs to outcome at a minimum As part of the effort,…